iodixanol has been researched along with Response Evaluation Criteria in Solid Tumors in 2 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Response Evaluation Criteria in Solid Tumors: An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, S | 1 |
| Fuld, MK | 1 |
| Laheru, D | 1 |
| Huang, P | 1 |
| Fishman, EK | 1 |
| Andersen, IR | 1 |
| Olesen, R | 1 |
| Boysen, AK | 1 |
| Jensen, LH | 1 |
| Mortensen, FV | 1 |
| Nielsen, DT | 1 |
| Rasmussen, F | 1 |
1 review available for iodixanol and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Fe | 2018 |
1 other study available for iodixanol and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib.
Topics: Abdominal Neoplasms; Aged; Biomarkers; Colorectal Neoplasms; Contrast Media; Female; Four-Dimensiona | 2019 |